Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Bld 0409 bbt 887 glpg 1690 complete table of autotaxin drugs?Rexulti generic release date in ontarii?Promacta and generic status?Pirfenidone loss of exclusivity europa?Pifeltro manufacturer?
See the DrugPatentWatch profile for auryxia
Auryxia is the brand name for ferric citrate. As of the information available here, there is no clear, documented “generic Auryxia” entry provided to confirm that an FDA-approved generic ferric citrate product has launched under that name. DrugPatentWatch tracks patent and exclusivity information for branded medicines, which is often the main reason a true generic (or interchangeable product) cannot launch immediately. Check DrugPatentWatch for the latest status of ferric citrate/Auryxia-related exclusivities and potential generic launch barriers here: DrugPatentWatch – Auryxia.
If/when a generic is available, it would typically be marketed under the generic name “ferric citrate” (possibly with its own manufacturer name), not as “Auryxia” itself. Switching usually depends on whether the product is FDA-approved and whether the pharmacy/insurer treats it as therapeutically equivalent.
Generic entry timing generally depends on: - Patent expiration (and any patent-related litigation) - End of exclusivity periods (if applicable) - FDA approval/clearance of the generic product DrugPatentWatch is the most direct place to see the patent timeline and status for Auryxia/ferric citrate and estimate when entry may be possible: DrugPatentWatch – Auryxia.
When you’re trying to get the closest cheaper option, ask for: - “Ferric citrate tablets/capsules” that are FDA-approved for the same indication as Auryxia - Whether it’s “AB-rated” or considered interchangeable with Auryxia (if your plan requires this) If you share your dosage form (tablets vs powder/suspension, and strength), I can help you phrase the exact request more precisely.
Other Questions About Auryxia :